Bachem Holding AG (LON:0QND)

Market Cap	3.89B
Revenue (ttm)	508.76M
Net Income (ttm)	100.00M
Shares Out	n/a
EPS (ttm)	1.34
PE Ratio	38.87
Forward PE	n/a
Dividend	0.70 (1.22%)
Ex-Dividend Date	Apr 26, 2024

Volume	3,022
Average Volume	17,327
Open	57.95
Previous Close	57.75
Day's Range	57.30 - 58.10
52-Week Range	54.70 - 105.30
Beta	0.75
RSI	55.53
Earnings Date	Feb 27, 2025

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, an...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1971
• Employees: 2,006
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QND

Financial Performance

In 2023, Bachem Holding AG's revenue was 577.32 million, an increase of 8.57% compared to the previous year's 531.74 million. Earnings were 111.86 million, an increase of 11.10%.

Financial numbers in CHF